International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Meet Our Newest Councilors

IPC is pleased to introduce and welcome our five newest Councilors for 2022: Pravit Asawanonda, Sunil Dogra, Benjamin Ehst, Filip Rob, and Tsen-Fang Tsai. These individuals were confirmed by the IPC Board of Directors during the European Academy of Dermatology and Venereology (EADV) Congress in September. They bring a diverse and broad experience in the field of psoriasis and are passionate about working to improve care for psoriasis patients around the world. IPC Councilors serve in an advisory capacity and lend their global expertise on psoriasis research, treatment, and education to support all IPC programs, events, and initiatives. They are selected based on their overall reputation in the dermatology community, experience in clinical or investigative research in psoriasis, level of clinical expertise in patient care, and demonstrated professional interest in psoriasis. Learn more about IPC Councilors and read their full biographies.

Our Newest Councilors

Pravit Asawanonda, MD, MSc, DSc

Chulalongkorn University

Bangkok, Thailand

Bio

Sunil Dogra, MD, DNB, FAMS, FRCP

Postgraduate Institute of Medical Education & Research

Chandigarh, India

Bio

Benjamin Ehst, MD, PhD

Oregon Medical Research Center

Portland, Oregon, United States

Bio

Filip Rob, MD, PhD

Charles University

Prague, Czech Republic

Bio

Tsen-Fang Tsai, MD

National Taiwan University Hospital

Taipei, Taiwan

Bio

Categories

Recent Posts

Commentary -Tiago Torres

Commentary: Trajectories and Prognosis after Discontinuation of Biologics due to Remission in Psoriasis – A Nationwide Cohort Study

Expert Insights IPC and IFPA CEO

IFPA and IPC Partnership One Year Later — Joining the Clinical and Patient Perspectives

New Councilor Headshots

Meet Our Newest Councilors

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.